loadpatents
name:-0.044867038726807
name:-0.042065858840942
name:-0.0047869682312012
Will; David William Patent Filings

Will; David William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Will; David William.The latest application filed is for "bicyclic heteroaromatic urea or carbamate compounds for use in therapy".

Company Profile
4.36.38
  • Will; David William - Heidelberg DE
  • Will; David William - Frankfurt am Main DE
  • Will; David William - Frankfurt N/A DE
  • Will; David William - Kriftel DE
  • WILL; David William - Berlin DE
  • Will; David William - Schwalbach DE
  • Will; David William - Eschborn DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bicyclic Heteroaromatic Urea Or Carbamate Compounds For Use In Therapy
App 20210147405 - Will; David William ;   et al.
2021-05-20
Benzofuran Amides And Heteroaromatic Analogues Thereof For Use In Therapy
App 20200223837 - Will; David William ;   et al.
2020-07-16
Benzofuran Ureas Or Carbamates And Heteroaromatic Analogues Thereof For Use In Therapy
App 20200216434 - Will; David William ;   et al.
2020-07-09
Bicyclic Heteroaromatic Amide Compounds For Use In Therapy
App 20200216435 - Will; David William ;   et al.
2020-07-09
Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
Grant 8,642,620 - Strobel , et al. February 4, 2
2014-02-04
Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
Grant 8,518,976 - Strobel , et al. August 27, 2
2013-08-27
Imidazo[1,2-a]pyridines and their use as pharmaceuticals
Grant 8,399,476 - Zoller , et al. March 19, 2
2013-03-19
Heteroarylacrylamides and their use as pharmaceuticals
Grant 8,304,438 - Strobel , et al. November 6, 2
2012-11-06
Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
Grant 8,299,102 - Strobel , et al. October 30, 2
2012-10-30
Heteroaryl-substituted carboxamides and their use as pharmaceuticals
Grant 8,188,291 - Strobel , et al. May 29, 2
2012-05-29
Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals
Grant 8,168,665 - Zoller , et al. May 1, 2
2012-05-01
Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
Grant 8,080,569 - Zoller , et al. December 20, 2
2011-12-20
Imidazo[1,2-a]azines and their use as pharmaceuticals
Grant 8,044,050 - Zoller , et al. October 25, 2
2011-10-25
Pyridazinone kinase inhibitors
Grant 7,968,546 - Hoelder , et al. June 28, 2
2011-06-28
Pyrazole-derivatives as factor Xa inhibitors
Grant 7,910,606 - Nazare , et al. March 22, 2
2011-03-22
Polyamide nucleic acid derivatives and agents, and processes for preparing them
Grant 7,897,346 - Uhlmann , et al. March 1, 2
2011-03-01
4-benzimidazol-2-ylpyridazin-3-one derivatives
Grant 7,754,713 - Hoelder , et al. July 13, 2
2010-07-13
IMIDAZO[1,2-a]AZINES AND THEIR USE AS PHARMACEUTICALS
App 20100137321 - ZOLLER; Gerhard ;   et al.
2010-06-03
4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
Grant 7,727,989 - Schoenafinger , et al. June 1, 2
2010-06-01
IMIDAZO[1,2-a]PYRIDINES AND THEIR USE AS PHARMACEUTICALS
App 20100113412 - ZOLLER; Gerhard ;   et al.
2010-05-06
Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
Grant 7,709,466 - Hoelder , et al. May 4, 2
2010-05-04
Heteroarylacrylamides And Their Use As Pharmaceuticals
App 20100016272 - STROBEL; Hartmut ;   et al.
2010-01-21
Heteroarylcyclopropanecarboxamides And Their Use As Pharmaceuticals
App 20100016278 - STROBEL; Hartmut ;   et al.
2010-01-21
Heteroaryl-substituted Carboxamides And Their Use As Pharmaceuticals
App 20100016337 - STROBEL; Hartmut ;   et al.
2010-01-21
Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
App 20100004299 - ZOLLER; Gerhard ;   et al.
2010-01-07
Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals
App 20090239915 - ZOLLER; Gerhard ;   et al.
2009-09-24
Polyamide nucleic acid derivatives and agents, and processes for preparing them
Grant 7,550,582 - Uhlmann , et al. June 23, 2
2009-06-23
Novel Pyridazinone Derivatives
App 20090130209 - HOELDER; Swen ;   et al.
2009-05-21
Pyridazinone derivatives
Grant 7,507,734 - Hoelder , et al. March 24, 2
2009-03-24
New Indole Derivatives As Factor Xa Inhibitors
App 20090069565 - NAZARE; Mark ;   et al.
2009-03-12
Novel 4-benzimidazol-2-ylpyridazin-3-one Derivatives
App 20090042880 - HOELDER; Swen ;   et al.
2009-02-12
Method for producing 1,4-diphenyl azetidinone derivatives
Grant 7,488,818 - Lindenschmidt , et al. February 10, 2
2009-02-10
4-benzimidazol-2-ylpyridazin-3-one derivatives
Grant 7,470,689 - Hoelder , et al. December 30, 2
2008-12-30
Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
Grant 7,462,613 - Holder , et al. December 9, 2
2008-12-09
Azaindole-Derivatives As Factor Xa Inhibitors
App 20080280946 - NAZARE; Marc ;   et al.
2008-11-13
Guanidine and amidine derivatives as factor Xa inhibitors
Grant 7,435,747 - Peyman , et al. October 14, 2
2008-10-14
Heteroaryl-Substituted Amides Comprising A Saturated Linker Group, And Their Use As Pharmaceuticals
App 20080171739 - STROBEL; Harmut ;   et al.
2008-07-17
Heteroaryl-Substituted Amides Comprising An Unsaturated Or Cyclic Linker Group, And Their Use As Pharmaceuticals
App 20080167342 - STROBEL; Harmut ;   et al.
2008-07-10
Azaindole-derivatives as factor Xa inhibitors
Grant 7,317,027 - Nazare , et al. January 8, 2
2008-01-08
Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
Grant 7,309,701 - Holder , et al. December 18, 2
2007-12-18
Novel Pyridazinone Derivatives
App 20070259870 - HOELDER; Swen ;   et al.
2007-11-08
Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
App 20070173503 - Hoelder; Swen ;   et al.
2007-07-26
Polyamide nucleic acid derivatives, and agents, and processes for preparing them
Grant 7,241,882 - Uhlmann , et al. July 10, 2
2007-07-10
Method For Producing 1,4-diphenyl Azetidinone Derivatives
App 20070149776 - LINDENSCHMIDT; Andreas ;   et al.
2007-06-28
Pyridazinone Derivatives, Methods For Their Production And Their Use As Pharmaceuticals
App 20070088041 - Hoelder; Swen ;   et al.
2007-04-19
4-benzimidazol-2-yl-pyridazine-3-one-derivatives, Production And Use Thereof In Medicaments
App 20070072866 - SCHOENAFINGER; Karl ;   et al.
2007-03-29
Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
Grant 7,067,665 - Nazare , et al. June 27, 2
2006-06-27
Oxybenzamide derivatives useful for inhibiting factor Xa or viia
Grant 6,953,857 - Nazare , et al. October 11, 2
2005-10-11
Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
App 20050165058 - Nazare, Marc ;   et al.
2005-07-28
Guanidine and amidine derivatives as factor Xa inhibitors
App 20050143419 - Peyman, Anuschirwan ;   et al.
2005-06-30
Indole derivatives as factor Xa inhibitors
Grant 6,906,084 - Nazare , et al. June 14, 2
2005-06-14
Polyamide nucleic acid derivatives, and agents and processes for preparing them
Grant 6,905,820 - Uhlmann , et al. June 14, 2
2005-06-14
New indole derivatives as factor Xa inhibitors
App 20050043302 - Nazare, Marc ;   et al.
2005-02-24
Novel pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
App 20050026918 - Holder, Swen ;   et al.
2005-02-03
Modified antisense nucleotides complementary to a section of the human haras gene
App 20050020523 - Uhlmann, Eugen ;   et al.
2005-01-27
Azaindole-derivatives as factor Xa inhibitors
App 20050009828 - Nazare, Marc ;   et al.
2005-01-13
Polyamide nucleic acid derivatives, and agents, and processes for preparing them
App 20040265885 - Uhlmann, Eugen ;   et al.
2004-12-30
Novel pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them
App 20040176377 - Holder, Swen ;   et al.
2004-09-09
Polyamide nucleic acid derivatives and agents and processes for preparing them
Grant 6,777,544 - Uhlmann , et al. August 17, 2
2004-08-17
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
Grant 6,747,148 - Peyman , et al. June 8, 2
2004-06-08
Modified antisense nucleotides complementary to a section of the human Ha-ras gene
Grant 6,723,706 - Uhlmann , et al. April 20, 2
2004-04-20
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
Grant 6,660,728 - Scheunemann , et al. December 9, 2
2003-12-09
New indole derivatives as factor Xa inhibitors
App 20030199689 - Nazare, Marc ;   et al.
2003-10-23
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
App 20030153557 - Scheunemann, Karl-Heinz ;   et al.
2003-08-14
Modified Antisense Nucleotides Complementary To A Section Of The Human Ha-ras Gene
App 20030064514 - UHLMANN, EUGEN ;   et al.
2003-04-03
Polyamide nucleic acid derivatives and agents and processes for preparing them
App 20030022172 - Uhlmann, Eugen ;   et al.
2003-01-30
New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
App 20020198195 - Nazare, Marc ;   et al.
2002-12-26
Polyamide nucleic acid derivatives, and agents and processes for preparing them
App 20020187473 - Uhlmann, Eugen ;   et al.
2002-12-12
Guanidine and amidine derivatives as factor Xa inhibitors
App 20020173656 - Peyman, Anuschirwan ;   et al.
2002-11-21
Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
App 20020065271 - Peyman, Anuschirwan ;   et al.
2002-05-30
Process for preparing substituted N-ethyglycine derivatives
Grant 5,817,811 - Breipohl , et al. October 6, 1
1998-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed